Example: Heart Attack
Search clinical trials for: Angiogenesis Modulating Agents
Total 0 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Anaplastic Oligodendroglioma (AO)
- Childhood Chronic Immune Thrombocytopenia
- Dyslipidemia & Hypertension
- Laparotomy
- Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
- Parenting Behaviour
- Pediatric Aggression and Violence
- Precursors to PCOS
- Respiratory Distress Syndrome (RDS)
- SCUBA Diving
- Solid Pseudopapillary Tumors of the Pancreas
- Sperm Quality
- Subfoveal Choroidal Neovascularization
- View Full List
Sponsors and Collaborators
- Analgesic Solutions
- Biomaterials Research Center, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea
- D'Or Institute for Research and Education
- Education-Plus, Inc.
- Francisco Colomina Climent
- Heart Metabolics Limited
- Lionel Perrier Foundation (Montreux, Switzerland)
- Mylan Pharmaceuticals
- Richard Zellars
- RightBio Metrics
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- The New York Society for the Prevention of Cruelty to Children
- Virginia State University
- View Full List
Drug Interventions
- BI 1356 BS, low dose
- Baseline regimen of cobicistat-boosted elvitegravir
- Docetaxel (D)
- Gemcitabine + Sunitinib
- Injectable Placebo
- KH001 for MAD
- Lamotrigine polytherapy including valproate
- Paxalisib
- Placebo nasal aerosol
- SNX-001
- Toripalimab Combined With S1 and Albumin Paclitaxel
- ipratropium bromide alone or in fixed dose combination with albuterol
- temozolomide 60 mg x 21 days
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations